In this study the anti-tumour effects of a selective COX-2 inhibitor, SC-236, and the non-selective inhibitor, indomethacin were investigated in an orthotopic model of established breast cancer (Pulaski and Ostrand-Rosenberg, 1998). The gene discussed is PTGS2; the disease is breast carcinoma.